
Carbimazole
Composition
The formulation Contains carbimazole as the active ingredient.
Indications
treatment of hyperthyroidism
Side effects
Nausea, vomiting, rash, and arthralgia. Serious side effects can include agranulocytosis and hepatotoxicity.
Precautions
Regular blood count monitoring, Use with caution in patients with liver impairment or a history of bone marrow suppression
Contraindications
Contraindicated in patients with known hypersensitivity to carbimazole or any component of the formulation, as well as in patients with aplastic anemia
Dosage and administration
typically divided into multiple doses throughout the day
Countries
UK, Ireland, India
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai